The global In-Vivo Toxicology Testing market reached a value of about USD 8.6 billion in 2021. The industry is projected to grow at a CAGR of around 9.5% in the forecast period of 2022-2027 to reach a value of about USD 14.82 billion by 2027.
The global In-Vivo Toxicology Testing industry report gives a comprehensive analysis of the industry, including key segments, trends, drivers, restraints, the competitive landscape, and other essential market aspects. The demand for toxicology testing to understand the hazardous consequences of various chemical compounds on humans drives the market's expansion. North America is the highest category spender by region, driving the demand for the In-Vivo Toxicology Testing industry.
In Vivo, Toxicology refers to scientific research conducted within an intact, live creature, such as a laboratory animal, to better understand the hazardous consequences of various chemical compounds supplied to the test subject. These tests can also check that the medicine or substance of choice is free of dangerous substances. In-vivo testing is used in preclinical studies. The In-Vivo Toxicology Testing industry report comprises segments by end-use (pharmaceuticals, chemical and agrochemicals) and region (North America, Europe, Asia Pacific, the Middle East, Africa, and Latin America).
North America holds the largest share in the industry, which comprises the United States and Canada. Because of its technological superiority and the presence of significant firms, the region is dominating the industry. In addition, the presence of key players operating in the in vivo toxicology market and expanding biomedical research in the United States and rising preclinical activities by CROs and pharmaceutical firms in the region account for the region's prominent position.
The changing dynamics are driving the market in the global healthcare market, which has driven pharmaceutical and biotechnology businesses to create treatments that provide substantial value rather than merely incremental improvements. As a result, many pharmaceutical and medical device companies focus on newer innovations and improving their R&D efficiency. The pharmaceutical market will benefit from increased demand for innovative therapies, which will feed a need for clinical studies of new drug candidates. In addition, the growing popularity of humanised animal models, which are valuable tools for doing preclinical research and learning more about human biology, is further boosting industry growth. The desire to understand how medications affect people and an increasing interest in researching human-specific infections, treatments and immunological responses drive the development and usage of humanised animal models. Also, the government's compulsory in-vivo testing will support the segment's growth in the future.
The global In-Vivo Toxicology Testing industry report by Procurement Resource gives an in-depth analysis of the best buying practices followed by major global In-Vivo Toxicology Testing regions, such as engagement models and contract terms, and buyer and supplier negotiation levers, among others.
Animal research and clinical trials are the two most common forms of in vivo tests. Researchers use animal studies to learn more about the mechanisms that underpin various disease processes and test new medicinal therapies' safety. The majority of animal research employs genetically identical laboratory-bred mice or rats. As a result, scientists can keep track of various biological impacts on complex organisms. Researchers test potential novel medicines or procedures in the lab and animals before moving them into human clinical trials. Clinical studies are divided into many stages. During an investigation, researchers learn more about the prospective therapy, its hazards, how it could or might not work, and quality of life aspects.
The industry is witnessing development due to various technologies that provide alternatives to animal testing. Regulatory compliance also requires service providers to limit the number of in-vivo models by employing the 3R concept. CROs are increasingly utilising the 3R (Replace, Refine, and Reduce) to minimise the number of animals used in toxicological investigations. Pharmaceutical R&D efforts are expanding, as are animal model advances, the creation of exclusive in vivo toxicological testing, and the growing need for individualised treatment and innovative therapies.
However, the market may decline due to pressure from animal welfare groups like PETA. On the other hand, researchers and toxicologists are looking for alternatives to animal testing, likely to create new market opportunities.
The regional markets for the industry can be divided into North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.
Market participants use organic and inorganic tactics to enhance their market share and client base and solidify their market share. Because the amount of work is not huge and thus helps create a connection before participating in strategic collaboration, the majority of the suppliers (small Biotech) adopted the project by project approach. Strategic partnerships are becoming more popular.
1. Executive Summary
2. In-Vivo Toxicology Testing Market Snapshot
2.1. In-Vivo Toxicology Testing Market Outlook
2.2. In-Vivo Toxicology Testing Industry Analysis by End Use
2.3. Region Overview
2.3.1. North America
2.3.2. Asia Pacific
2.3.4. Latin America
2.3.5. Middle East and Africa
3. Impact of Recent Events
4. In-Vivo Toxicology Testing Value Chain Analysis
5. In-Vivo Toxicology Testing Production Process
6. Trade Analysis
7. Major Risk Factors in Sourcing
8. In-Vivo Toxicology Testing Cost Structure
9. In-Vivo Toxicology Testing Price Analysis
10. Key Demand Indicator Analysis
11. Key Price Indicator Analysis
12. In-Vivo Toxicology Testing Market Dynamics
12.1. Drivers & Constraints
12.2. Industry Events
12.3. Innovations & Trends
12.4. Swot Analysis
12.5. Porter’s Five Forces
12.5.1. Buyer Power
12.5.2. Supplier Power
12.5.3. Threat of New Entrants
12.5.4. Threat of Substitutes
12.5.5. Industry Rivalry
13. Industry Best Practices
13.1. Sourcing Strategy
13.2. Procurement Model
13.3. Contract Structure
13.4. Negotiation Levers
13.5. Pricing Model
13.6. Key Factors Influencing the Quotation
14. Key Supplier Analysis
14.1. Charles River Laboratories International, Inc
14.2. Labcorp Drug Development
14.3. Eurofins Scientific, S.E.
14.4. WuXi AppTec Co., Ltd.
14.5. Creative Animodel
The global In-Vivo Toxicology Testing market size was valued at USD 8.6 billion in 2021.
As per the Industry provided, the pharmaceuticals segment is anticipated to lead the market between the period 2022 – 2027.
The significant demand for the 3R (Replace, Refine, and Reduce) method is one of the essential drivers of the In-Vivo Toxicology Testing market growth.
Charles River Laboratories International, Inc, Labcorp Drug Development, Eurofins Scientific, S.E., WuXi AppTec Co., Ltd. and Creative Animodel are some of the major companies in the market.
The North American region of the In-Vivo Toxicology Testing industry holds a significant share in the market.
The global In-Vivo Toxicology Testing market attained a value of USD 8.6 billion in 2021, driven by the changing dynamics in the global healthcare markets, which have driven pharmaceutical and biotechnology businesses to create treatments that provide substantial value rather than merely incremental improvements. Aided by the emergence of various technologies that offer alternatives to animal testing, the market is expected to witness further growth in the forecast period of 2022-2027, growing at a CAGR of 9.5%. The market is projected to reach USD 14.82 billion by 2027. Some of the leading players in the industry are Charles River Laboratories International, Inc, Labcorp Drug Development, Eurofins Scientific, S.E., WuXi AppTec Co., Ltd. and Creative Animodel.
Procurement Resources' detailed research approach explores deep into the industry, encompassing the macro and micro aspects of the industry. Its team of experts uses a combination of cutting-edge analytical tools and their expertise, thus, delivering its customers with market insights that are accurate and actionable and help them remain ahead of their competition.
At Procurement Resource our analysts are selected after they are assessed thoroughly on having required qualities so that they can work effectively and productively and are able to execute projects based on the expectations shared by our clients. Our team is hence, technically exceptional, strategic, pragmatic, well experienced and competent.
We understand the cruciality of high-quality assessments that are important for our clients to take timely decisions and plan strategically. We have been continuously upgrading our tools and resources over the past years to become useful partners for our clientele. Our research methods are supported by most recent technology, our trusted and verified databases that are modified as per the needs help us serve our clients effectively every time and puts them ahead of their competitors.
Our team provides a detailed, high quality and deeply researched evaluations in competitive prices, that are unmatchable, and demonstrates our understanding of our client’s resource composition. These reports support our clientele make important procurement and supply chains choices that further helps them to place themselves ahead of their counterparts. We also offer attractive discounts or rebates on our forth coming reports.
Our vision is to enable our clients with superior quality market assessment and actionable evaluations to assist them with taking timely and right decisions. We are always ready to deliver our clients with maximum results by delivering them with customised suggestions to meet their exact needs within the specified timeline and help them understand the market dynamics in a better way.
Email Delivery Price: $ 999.00
The global Artificial Intelligence market reached a value of about USD 192 Billion in 2021. The industry is projected to grow at a CAGR of around 23% in the forecast period of 2022-2027 to reach a value of about USD 664.86 Billion by 2027.Read More
Email Delivery Price: $ 999.00
The global nutmeg market reached a value of about 130 thousand tonnes in 2021. The industry is further expected to grow at a CAGR of about 6% in the forecast period of 2022-2027 to reach a value of around 180 thousand tonnes by 2027.Read More
Email Delivery Price: $ 999.00
The global HEOR market reached a value of about USD 1364.3 million in 2021. The industry is further expected to grow at a CAGR of about 12.81% in the forecast period of 2022-2027 to reach a value of around USD 2779.2 million by 2027.Read More